(Q46536784)

22 December 2017

title

Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats (English)

1 reference

22 December 2017

1 reference

1 reference

Yutaka Kitano

1

1 reference

22 December 2017

Chika Komiyama

2

1 reference

22 December 2017

Mitsuhiro Makino

3

1 reference

22 December 2017

Kiyoshi Takasuna

4

1 reference

22 December 2017

Akira Takazawa

5

1 reference

22 December 2017

Shinobu Sakurada

6

1 reference

22 December 2017

publication date

1 June 2005

1 reference

22 December 2017

published in

Epilepsia

1 reference

22 December 2017

volume

46

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

811-818

1 reference

22 December 2017

Piracetam and other structurally related nootropics

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Taking stock of cognition enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Effects of nefiracetam on amnesia animal models with neuronal dysfunctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Effects of DM-9384 in a model of amnesia based on animals with GABAergic neuronal dysfunctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Cellular mechanisms underlying cognition-enhancing actions of nefiracetam (DM-9384).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

21 January 2018

Pyrrolidone derivatives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Basic science and epilepsy: experimental epilepsy surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Increasing-current electroshock seizure test: a new method for assessment of anti- and pro-convulsant activities of drugs in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

The new antiepileptic drugs: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

The protective action of nefiracetam against electrophysiological and metabolic damage in the hippocampus after deprivation of glucose and oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

The cognition-enhancer nefiracetam is protective in BDNF-independent neuronal cell death under the serum-free condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

The cognition-enhancer nefiracetam inhibits both necrosis and apoptosis in retinal ischemic models in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Effects of the subacute administration of nefiracetam on abnormal behavior in aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Revisiting the concept of identifiable neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

Selective blockade of N-type calcium channels by levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

New visions in the pharmacology of anticonvulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

The nootropic concept and its prospective implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.66504.X

10.1111/J.1528-1167.2005.66504.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017